NovelStem International Corp. (NSTM)

0.0600 0.0000 (0.00%) At close: 12:07PM EDT

NovelStem International Corp.

2255 Glades Road
Suite 221A
Boca Raton, FL 33431
United States
410 654 3315
https://www.novelstem.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Jan H. Loeb	Executive Chairman & President	N/A	N/A	1959
Mr. Mitchell Rubenstein	Co-Founder & Independent Director	N/A	N/A	1954
Ms. Christine Jenkins	VP, CFO & Secretary	54k	N/A	1964
Mr. David Collins	Investor Relations Firm, Catalyst IR	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.

Corporate Governance

NovelStem International Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.